Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famotidine and vitamin B6 add-on to aripiprazole in schizophrenia
IRCT20150822023705N16Phase 2Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of famotidine, pyridoxine and aripiprazole in schizophrenia (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Severity of negative symptoms. Started May 2023; status: completed.
02
Drugs
famotidinepyridoxinearipiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT20150822023705N16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150822023705N16.